fashion -WSS

fashion

author：comprehensive 2025-10-02 08:24:19 - browse：54

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Bird flu in milk supply is likely coming from asymptomatic cows

WSS

FTC falls short on scrutinizing hospital mergers, study says

Health care needs a new profession: neuroimaging counseling

Exact Sciences stock tumbles despite strong cancer detection sales

Experimental asthma app from Apple and Anthem shows promise

Medical bills so high, Medicare adding extra digits to claim forms

Readout Newsletter: Zepbound, Valneva's vaccine, and more

hotspot

fashion

focus

Wildfire smoke exposes gaps in outdoor worker protections

Cell therapy fails to slow type 1 diabetes, but safety is established

Trump demands the U.S. pay no more for drugs than other countries … again

MassMutual is introducing free genetic testing for members

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

More tobacco lobbyists active in statehouses

DIEP, the 'gold standard' of breast reconstruction, is under threat

More tobacco lobbyists active in statehouses

How one medical school became remarkably diverse

More tobacco lobbyists active in statehouses

explore

CVS, Rite Aid closures threaten to worsen pharmacy deserts

UnitedHealth financials solid despite Change Healthcare cyberattack

A letter from the executive editor: STAT UnitedHealth investigation

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

explore

entertainment

focus

leisure time